Возраст домена | 18 лет |
Дата окончания | Истек срок регистрации |
PR | 4 |
ИКС | |
Страниц в Google | 154 |
Страниц в Яндексе | 62 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | Нет данных |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Sanofi Genzyme Homepage - Sanofi Genzyme
Sanofi Genzyme, treatments, therapies, therapeutics, manufacturing, research, science, development, R&D, patients, access to treatment, support services, patient programs, patient assistance, responsible business, corporate responsibility, social responsibility, corporate citizenship, commitment, humanitarian, genetic disesase, rare disease, endocrinology, enzyme replacement therapy
Sanofi Genzyme focuses on developing specialty treatments for debilitating diseases that are often difficult to diagnose and treat, providing hope to patients and their families.
UTF-8
45.31 КБ
332
2 712 симв.
2 316 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
wikipedia.org | 8 | 9 |
0 | 5 | 6 | |
academic.ru | 4 | 7 |
0 | 1289 | 106 | |
vocabulary.ru | 3 | 4 |
0 | 120331 | 9793 | |
eurolab.ua | 3 | 5 |
0 | 83161 | 10908 | |
gismeteo.ru | 3 | 7 |
0 | 425 | 15 | |
rare-diseases.ru | 2 | 5 |
90 | 3153681 | Нет данных | |
medlinks.ru | 2 | 5 |
2600 | 32405 | 2325 | |
kdcenter.ru | 2 | 2 |
0 | 5738876 | Нет данных | |
dnalab.ru | 2 | 3 |
425 | 1206086 | 89600 | |
da-med.ru | 2 | 2 |
0 | 4129972 | 355252 | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 9 Июля 2013 ) | |
Количество ссылок на сайт | 233 |
Количество доменов, которые ссылаются на сайт | 19 |
Количество найденных анкоров | 9 |
Исходящие (внешние) ссылки домена | 109 |
Количество доменов, на которые ссылается сайт | 41 |
Количество исходящих анкоров | 20 |
Внешние ссылки главной страницы ( 5 ) | |
sanofi.com/en/directory/ | Worldwide presence |
facebook.com/SanofiGenzyme/ | Sanofi Genzyme on Facebook |
linkedin.com/company/sanofigenzyme | Sanofi Genzyme on LinkedIn |
twitter.com/SanofiGenzyme | Sanofi Genzyme on Twitter |
youtube.com/user/GenzymeCorporate/ | Sanofi Genzyme on YouTube |
Внутренние ссылки главной страницы ( 21 ) | |
# | <img> |
/en | <img> |
/en/search-results/ | <div> |
/en/about-us | LEARN MORE |
/en/areas-of-focus/rare-diseases | Rare Diseases |
/en/areas-of-focus/oncology | Oncology |
/en/areas-of-focus/rare-blood-disorders | Rare Blood Disorders |
/en/areas-of-focus/immunology | Immunology |
/en/areas-of-focus/multiple-sclerosis | Multiple Sclerosis |
/en/about-us/newsroom/2019/2019-10-10-08-00-00 | 2019-10-10MMMM DD YYYYPress releases Innovative treatment Cablivi (caplacizumab-yhdp) granted new technology payment (NTAP) for ... |
/en/about-us/newsroom/2019/2019-09-30-10-34-00 | 2019-09-30MMMM DD YYYYPress releases New England Journal of Medicine publishes data showing improved survival with Jevtana® (cab... |
/en/about-us/newsroom/2019/2019-09-20-07-05-00 | 2019-09-20MMMM DD YYYYPress releases The Lancet Publishes Results from Two Positive Phase 3 Trials of Dupixent® (dupilumab) in S... |
/en/about-us/newsroom | All Press Releases |
/en/about-us/our-stories/Supporting-children-whose-parents-h... | READ THE STORY |
/en/about-us/our-stories/Reflecting-on-25-years-of-service | READ THE STORY |
/en/about-us/our-stories/Infusion-Squad-Takes-Kids-with-Hemo... | READ THE STORY |
/en/products-research/research-pipeline | EXPLORE R&D HIGHLIGHTS |
/en/careers | DISCOVER OPPORTUNITIES |
/en/responsibility/patient-access-to-treatment | LEARN ABOUT OUR EFFORTS |
/en/contact-us | Send a message |
/en/privacy-policy | Click here for more information on cookies. |
[Querying whois.ripn.net]
[whois.ripn.net]
% By submitting a query to RIPN's Whois Service
% you agree to abide by the following terms of use:
% http://www.ripn.net/about/servpol.html#3.2 (in Russian)
% http://www.ripn.net/about/en/servpol.html#3.2 (in English).
domain: GENZYME.RU
nserver: ns1.sanofi-synthelabo.com.
nserver: ns2.sanofi-synthelabo.com.
nserver: ns3.sanofi-synthelabo.com.
nserver: ns4.sanofi-synthelabo.com.
state: REGISTERED, DELEGATED, VERIFIED
org: Genzyme Corporation
registrar: RU-CENTER-REG-RIPN
admin-contact: https://www.nic.ru/whois
created: 2006.06.15
paid-till: 2014.06.15
free-date: 2014.07.16
source: TCI
Last updated on 2013.09.02 12:36:33 MSK
Россия - Москва - 91.218.230.24
Hosting Operator eServer.ru Ltd.
Internet-Hosting Ltd
HTTP/1.1 200 OK
Pragma: no-cache
Content-Type: text/html; charset=utf-8
X-UA-Compatible: IE=Edge
Cache-Control: no-cache, no-store
Expires: Mon, 14 Oct 2019 11:52:10 GMT
Date: Mon, 14 Oct 2019 11:52:10 GMT
Content-Length: 46395
Connection: keep-alive
Strict-Transport-Security: max-age=15768000
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"